KUALA LUMPUR: Hartalega Holdings Bhd says demand for rubber gloves won’t be affected by vaccines for the Covid-19 coronavirus and will continue to outstrip supply in the next three to four years.
The pandemic has changed users’ behavior, that has resulted in the demand for gloves, chairman Kuan Kam Hon told reporters. Demand for usage in developed countries have increased 30% while in developing countries, usage has more than doubled, he says.
The industry cannot meet the 120b of additional demand for gloves. This demand can only be fulfilled in three years, he adds.
Spot prices for gloves have jumped 30% this quarter and he expects them to increase 40-50% in coming quarters, he says.
Glove prices are now three times higher compared to those during pre-covid-19.
Hartalega earmarked RM1.5bil investment to build four plants, of which first two lines will be operational by October 2021.
Another RM3bil is for its next expansion phase, its so-called NGC2, which will be fully completed in seven years. - Bloomberg
Why listed company like Mahsing or other want to start up gloves company which require abt one yr to start operation , why not acquire Comfort from open market to save all the trouble of buying suitable land , machinery , employ skill workers etc .....
LMAO, China reported 60k people injected with covid vaccine with no one infected and glove counter remain uptrend. US less than 100 people injected with vaccine and reported 90% effective, glove counter drop like hell.
more glove is required for vaccination process. furthermore each of us may need vaccination for more than one dos as it to be effective. the whole world population need to be vaccine. count the number of glove required for the process. and this process will take at least 2 years to complete. so it it obvious that the demand of glove will remain at least until 2023.
This is just short term selling off. If you look at Mahsing movement pr chart, it has down and is moving upward. Was derailed by vaccine news. I think those got holding power will benefits soon.
One more point to add, Mahsing is a property stock + venture in to glove. So vaccine news will be good for it property sector. Either way Mahsing benefits
Vaccine news caps rally of new glove industry entrants KUALA LUMPUR (Nov 10): The slew of companies that recently announced plans to enter the rubber glove business were broadly hit by a selldown this morning amid news that an experimental Covid-19 vaccine developed by Pfizer and its German partner BioNTech was more than 90% effective. As of 10.09am, shares in AT Systematization Bhd had slipped 11.6% or 2.5 sen to 19 sen. It was the most traded counter this morning, with 1.05 billion shares traded within two hours after the opening bell. Luster Industries Bhd was the seventh most actively traded stock today, with some 76.86 million shares done. It was down by 11.63% or 2.5 sen at 19 sen, valuing it at RM458.05 million. Meanwhile, HLT Global Bhd shares were trading 5.03% or eight sen lower at RM1.51, giving the stock a market capitalisation of RM925.99 million. HLT saw 8.77 million shares transacted. Mah Sing Group Bhd, whose share price had more than doubled after announcing its foray into the rubber glove space, dropped 5% or five sen to 95 sen apiece, translating into a market value of RM2.31 billion. As for Inix Technologies Holdings Bhd, it was down 6.52% or 1.5 sen at 21.5 sen, valuing it at RM89.76 million. The counter saw 2.45 million shares transacted. Titijaya Land Bhd fell by 1.21% or half a sen to 41 sen piece, valuing the property developer cum rubber glove and Covid-19 vaccine player at RM556.94 million. Meanwhile, Hong Seng Consolidated Bhd (formerly known as MSCM Holdings Bhd) was down by 2.83% or three sen at RM1.03.
Kanger bucks the trend However, Kanger International Bhd bucked the trend. Its share price was up 2.63% or half a sen at 19.5 sen. Thes stock was the third most actively traded counter on Bursa Malaysia, with 240.34 million shares done. The new entrants, except for HLT Global, have yet to commence glove production. The availability of the vaccine raises the question of whether growth in demand for disposable rubber gloves will remain as strong moving forward to absorb additional supply from the new entrants. The selldown seen among most of the new kids on the block in the rubber glove sector came after Pfizer made an overnight announcement that its Covid-19 vaccine candidate had a more than 90% efficacy rate with no serious concerns based on initial trial results. Pfizer is hoping to ship out up to 50 million doses this year for 25 million people, and produce 1.3 billion doses in 2021.
wong, thanks for the information, however, even vaccine is available next year but the reliability is questionable, glove demands will remain strong until 2024, Mah Sing is cash rich and AT is cheap.....
Today Mah Sing pull back 7% and AT Systematization pull back 12 % are very healthy considered all the weak contra players are all sold out, tomorrow will be a better day for us...
kd88, regarding your concerns about cold storage for vaccine, Kanger have team up with one specialised vaccine storage pharmacy to do that, pls check Kanger Web site for details...
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
SJSOON
2,576 posts
Posted by SJSOON > 2020-11-09 18:47 | Report Abuse
The model is like SCIENTEX. Future value should be $10 and above.